Pasar al contenido principal

CDK8 COMO DIANA PARA INDUCIR REJUVENECIMIENTO DE SUPERNEHANCERS EN CELULAS MADRE HEMATOPOYETICAS

PID2021-123922NB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2021
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario FUNDACIO INSTITUT D INVESTIGACIO BIOMEDICA DE BELLVITGE (IDIBELL)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Targeting RhoA nuclear mechanoactivity rejuvenates aged hematopoietic stem cells

  • Mejía-Ramírez, Eva
  • Iáñez Picazo, Pablo
  • Walter, Barbara
  • Montserrat-Vazquez, Sara
  • Affuso, Francesco
  • Wieser, Stefan
  • Pezzano, Fabio
  • Reymond, Loïc
  • Castillo-Robles, Jorge
  • Matteini, Francesca
  • Mularoni, Loris
  • Macià, Dídac
  • Raya Chamorro, Ángel
  • Ruprecht, Verena
  • Zheng, Yi
  • Petrone, Paula M.
  • Florian, Maria Carolina
Biomechanical alterations contribute to the decreased regenerative capacity of hematopoietic stem cells (HSCs) upon aging. RhoA is a key regulator of mechanosignaling, but its role in mechanotransduction in stem cell aging remains unclear. Here we show that murine HSCs respond to increased nuclear envelope (NE) tension by inducing NE translocation of P-cPLA2, which cell-intrinsically activates RhoA. Aged HSCs experience physiologically higher intrinsic NE tension, but reducing RhoA activity lowers NE tension in aged HSCs. Feature image analysis of HSC nuclei reveals that chromatin remodeling is associated with RhoA inhibition, including restoration of youthful levels of the heterochromatin marker H3K9me2 and a decrease in chromatin accessibility and transcription at retrotransposons. Finally, we demonstrate that RhoA inhibition upregulates Klf4 expression and transcriptional activity, improving aged HSC regenerative capacity and lympho/myeloid skewing in vivo. Together, our data outline an intrinsic RhoA-dependent mechanosignaling axis, which can be pharmacologically targeted to restore aged stem cell function., We thank support from L. Traveset Martinez, IDIBELL Innovation Unit. We acknowledge support from M. M. Gaudes, head of Technical Facilities at IDIBELL, together with J. A. Vaquero (IDIBELL FACS and Flow Cytometry SCT), A. Ventura (IDIBELL Mouse Facility SCT) and J. Repulles and S. Mendizuri (IDIBELL Bioimaging SCT). We also thank E. Castaño, B. Barroso and B. Torrejon (CCiT-UB, Bellvitge). We thank G. Lunazzi and the National Center for Genomic Analysis (CNAG, Barcelona) for support with scRNA-seq experiments. We thank the CERCA Program/Generalitat de Catalunya for institutional support. We thank C. Lazaro (LCAM laboratory, ICO-HUB) for supporting sequencing experiments. We acknowledge the following funding sources: European Research Council grant 101002453 (M.C.F.); Spanish Ministry of Science, Innovation and University grants RYC2018-025979-I (M.C.F.) and PGC2018-102049-B-I00 (M.C.F.) and PID2021-123922NB-I00 (M.C.F.); Department of Research and University of the Generalitat of Catalunya and AGAUR (expedient 2021 SGR 00888) (M.C.F.). P.I.P received an INPhINIT Incoming fellowship from "la Caixa" Foundation (ID 100010434) with code 2022-4167. P.P. and P.I.P. acknowledge support from the grant CEX2023-0001290-S funded by MCIN/AEI/ 10.13039/501100011033, and support from the Generalitat de Catalunya through the CERCA Program. P.P acknowledges her AI4S fellowship within the Generación D'initiative by Red.es, Ministerio para la Transformación Digital y de la Función Pública, for talent attraction (C005/24-ED CV1), funded by NextGenerationEU through PRTR. V.R. acknowledges financial support from the Ministerio de Ciencia e Innovación through the Plan Nacional (PID2020-117011GB-I00) and funding from the European Union's Horizon EIC-ESMEA Pathfinder program under grant agreement number 101046620.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Targeting RhoA nuclear mechanoactivity rejuvenates aged hematopoietic stem cells

  • Mejía-Ramírez, Eva
  • Iáñez Picazo, Pablo
  • Walter, Barbara
  • Montserrat-Vazquez, Sara
  • Affuso, Francesco
  • Wieser, Stefan
  • Pezzano, Fabio
  • Reymond, Loïc
  • Castillo-Robles, Jorge
  • Matteini, Francesca
  • Mularoni, Loris
  • Macià, Dídac
  • Raya Chamorro, Ángel
  • Ruprecht, Verena
  • Zheng, Yi
  • Petrone, Paula M.
  • Florian, Maria Carolina
Biomechanical alterations contribute to the decreased regenerative capacity of hematopoietic stem cells (HSCs) upon aging. RhoA is a key regulator of mechanosignaling, but its role in mechanotransduction in stem cell aging remains unclear. Here we show that murine HSCs respond to increased nuclear envelope (NE) tension by inducing NE translocation of P-cPLA2, which cell-intrinsically activates RhoA. Aged HSCs experience physiologically higher intrinsic NE tension, but reducing RhoA activity lowers NE tension in aged HSCs. Feature image analysis of HSC nuclei reveals that chromatin remodeling is associated with RhoA inhibition, including restoration of youthful levels of the heterochromatin marker H3K9me2 and a decrease in chromatin accessibility and transcription at retrotransposons. Finally, we demonstrate that RhoA inhibition upregulates Klf4 expression and transcriptional activity, improving aged HSC regenerative capacity and lympho/myeloid skewing in vivo. Together, our data outline an intrinsic RhoA-dependent mechanosignaling axis, which can be pharmacologically targeted to restore aged stem cell function., We thank support from L. Traveset Martinez, IDIBELL Innovation Unit. We acknowledge support from M. M. Gaudes, head of Technical Facilities at IDIBELL, together with J. A. Vaquero (IDIBELL FACS and Flow Cytometry SCT), A. Ventura (IDIBELL Mouse Facility SCT) and J. Repulles and S. Mendizuri (IDIBELL Bioimaging SCT). We also thank E. Castaño, B. Barroso and B. Torrejon (CCiT-UB, Bellvitge). We thank G. Lunazzi and the National Center for Genomic Analysis (CNAG, Barcelona) for support with scRNA-seq experiments. We thank the CERCA Program/Generalitat de Catalunya for institutional support. We thank C. Lazaro (LCAM laboratory, ICO-HUB) for supporting sequencing experiments. We acknowledge the following funding sources: European Research Council grant 101002453 (M.C.F.); Spanish Ministry of Science, Innovation and University grants RYC2018-025979-I (M.C.F.) and PGC2018-102049-B-I00 (M.C.F.) and PID2021-123922NB-I00 (M.C.F.); Department of Research and University of the Generalitat of Catalunya and AGAUR (expedient 2021 SGR 00888) (M.C.F.). P.I.P received an INPhINIT Incoming fellowship from "la Caixa" Foundation (ID 100010434) with code 2022-4167. P.P. and P.I.P. acknowledge support from the grant CEX2023-0001290-S funded by MCIN/AEI/ 10.13039/501100011033, and support from the Generalitat de Catalunya through the CERCA Program. P.P acknowledges her AI4S fellowship within the Generación D'initiative by Red.es, Ministerio para la Transformación Digital y de la Función Pública, for talent attraction (C005/24-ED CV1), funded by NextGenerationEU through PRTR. V.R. acknowledges financial support from the Ministerio de Ciencia e Innovación through the Plan Nacional (PID2020-117011GB-I00) and funding from the European Union's Horizon EIC-ESMEA Pathfinder program under grant agreement number 101046620.